Application of the Wei-Lachin multivariate one-directional test to multiple event-time outcomes

Clinical Trials

Volumn 12, Issue 6, 2015, Pages 627-633

  Lachin, John M ^a   Bebu, Ionut ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

Composite outcome; event time data; multivariate one directional test; Wei Lachin test

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; TRANDOLAPRIL;

ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; ENZYME INHIBITION; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROBABILITY; PROPORTIONAL HAZARDS MODEL; RISK REDUCTION; SCORING SYSTEM; WEI LACHIN TEST; CLINICAL TRIAL (TOPIC); OUTCOME ASSESSMENT; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS;

EID: 84947079904     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774515601027     Document Type: Article

References (19)

1. Bakal JA, Westerhout CM, Armstrong PW,. Impact of weighted composite compared to traditional composite endpoints for the design of randomized controlled trials. Stat Methods Med Res. Epub ahead of print 24 January 2014. DOI: 10.1177/0962280211436004.
2. Pocock SJ, Ariti CA, Collier TJ, et al. The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities. Eur Heart J 2012; 33: 176-182.
3. Claggett B, Tian L, Castagno D, et al. Treatment selections using risk-benefit profiles based on data from comparative randomized clinical trials with multiple endpoints. Biostatistics 2015; 16: 60-72.
4. Alosh M, Bretz F, Huque M,. Advanced multiplicity adjustment methods in clinical trials. Stat Med 2014; 33: 693-713.
5. Wei LJ, Lachin JM,. Two-sample asymptotically distribution-free tests for incomplete multivariate observations. J Am Stat Assoc 1984; 79: 653-661.
6. Lachin JM,. Some large sample size distribution-free estimators and tests for multivariate partially incomplete observations from two populations. Stat Med 1992; 11: 1151-1170.
7. Lachin JM,. Applications of the Wei-Lachin multivariate one-sided test for multiple outcomes on possibly different scales. PLoS ONE 2014; 9 (10): e108784.
8. Pipper CB, Ritz C, Bisgaard H,. A versatile method for confirmatory evaluation of the effects of a covariate in multiple models. J Roy Stat Soc C: App 2012; 61: 315-326.
9. Lin DY, Wei LJ,. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84: 1074-1078.
10. Wei LJ, Lin DY, Weissfeld L,. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. J Am Stat Assoc 1989; 84: 1065-1073.
11. Lin DY,. Cox regression analysis of multivariate failure time data: the marginal approach. Stat Med 1994; 13: 2233-2247.
12. Prentice RL, Kalbfleisch JD, Peterson AV, et al. The analysis of failure times in the presence of competing risks. Biometrics 1978; 34: 541-554.
13. Fine JP, Gray RJ,. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
14. Frick H,. A maximin linear test and its application to Lachin's data. Commun Stat A: Theor 1994; 23: 1021-1029.
15. Frick H,. Comparing trials with multiple outcomes: the multivariate one-sided hypothesis with unknown covariances. Biomet J 1995; 8: 909-917.
16. Lachin JM, Foulkes MA,. Evaluation of sample size and power for analyses of survival with allowance for non-uniform patient entry, losses to follow-up, non-compliance and stratification. Biometrics 1986; 42: 507-519.
17. The PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med 2004; 351: 2058-2068.
18. Therneau TM, Grambsch PM,. Modeling survival data: extending the Cox model. New York: Springer-Verlag.
19. Lachin JM,. Biostatistical methods: the assessment of relative risks. 2nd ed. New York: Wiley, 2011.